Newsletter Archives

Showing 1 to 20 of 903 articles.

EBM Focus - Volume 20, Issue 7

Expert Opinion in EBM: Screening for Heart Failure in People With Diabetes

MBE em Foco - Volume 11, Issue 2

Não se pode simplesmente “vomitar” orientações sobre o manejo pré-operatório dos agonistas do receptor de GLP-1

EBM Focus - Volume 20, Issue 6

Expert Opinion in EBM: Advances in Management of Metastatic Prostate Cancer

EBM Focus - Volume 20, Issue 5

Evidence-Based Solutions to the IV Fluid and Peritoneal Dialysis Solution Shortage

MBE em Foco - Volume 11, Issue 1

Opinião de Especialistas na MBE: Imagens Adjuvantes para o Rastreamento do Câncer de Mama

EBM Focus - Volume 20, Issue 4

Another mAb in the Mix for the Management of Severe Asthma

EBM Focus - Volume 20, Issue 3

Expert Opinion in EBM: Adjunctive Imaging for Breast Cancer Screening

EBM Focus - Volume 20, Issue 2

You Can’t Just Regurgitate Guidance on Preoperative Management of GLP-1 Receptor Agonists

EBM Focus - Volume 20, Issue 1

Is HPV Self-Sampling the New Cologuard?

MBE em Foco - Volume 10, Issue 9

Making Acetaminophen Safe Again na gestação

MBE em Foco - Volume 10, Issue 8

A batalha das bebidas pelo emagrecimento

MBE em Foco - Volume 10, Issue 7

Colchicina: mirando a inflamação para a prevenção secundária da DCV

EBM Focus - Volume 19, Issue 20

$emaglutide: Less Cost-Effective Than Endoscopic Sleeve Gastroplasty in the US

EBM Focus - Volume 19, Issue 19

Head-to-Head Analysis of Topical vs. Oral Minoxidil for Male Pattern Baldness

EBM Focus - Volume 19, Issue 18

Dying to Survive? Forty is the New 50 for Breast Cancer Screening

MBE em Foco - Volume 10, Issue 6

Estimulantes salvam vidas: os danos ocultos causados pelo TDAH não tratado

EBM Focus - Volume 19, Issue 17

Making Acetaminophen Safe (in Pregnancy) Again

MBE em Foco - Volume 10, Issue 6

Anticorpos monoclonais para a doença de Alzheimer: ouro de tolo

EBM Focus - Volume 19, Issue 16

A Battle of the Beverages for Better Weight Loss

EBM Focus - Volume 19, Issue 15

The Eyes Have It: Less Frequent, Higher-Dose Injections for Retinopathy Appear Just as Good